Latest news
21-08-2024 - New $6 Million Clinical Trial Awards to Evaluate Beta Cell Transplant Therapies for Type 1 Diabetes
Breakthrough T1D has issued a new Request for Applications to fund clinical trials to evaluate drugs and biologics to delay, halt, or reverse type 1 diabetes (T1D) through supporting or expanding endogenous beta cell survival and function and disrupting autoimmune pathobiology.
[...]